Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogier Versteeg

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Frontiers in Oncology|March 10, 2023
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastomaThomas F Eleveld, Lindy Vernooij, Linda Schild, et al.
Nature Communications|April 6, 2019
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastomaTim van Groningen, Nurdan Akogul, Ellen M Westerhout, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2014
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosisGitta Bleeker, Berthe L van Eck-Smit, Koos H Zwinderman, et al.
Nature Communications|January 28, 2015
Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancerLinda Holmquist Mengelbier, Jenny Karlsson, David Lindgren, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2021
Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastomaMarlinde L van den Boogaard, Rurika Oka, Anne Hakkert, et al.
The EMBO Journal|June 14, 2012
The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markersJavier Muñoz, Daniel E Stange, Arnout G Schepers, et al.
Acta Neuropathologica|November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.
Cancer Research|December 2, 2021
Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
JCO Precision Oncology|May 26, 2021
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease PanelEsther M van Wezel, Lieke M J van Zogchel, Jalenka van Wijk, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 26, 2017
Indian Hedgehog Suppresses a Stromal Cell-Driven Intestinal Immune ResponseB Florien Westendorp, Nikè V J A Büller, Olga N Karpus, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|March 10, 2023
MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastomaThomas F Eleveld, Lindy Vernooij, Linda Schild, et al.
Nature Communications|April 6, 2019
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastomaTim van Groningen, Nurdan Akogul, Ellen M Westerhout, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2014
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosisGitta Bleeker, Berthe L van Eck-Smit, Koos H Zwinderman, et al.
Nature Communications|January 28, 2015
Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancerLinda Holmquist Mengelbier, Jenny Karlsson, David Lindgren, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2021
Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastomaMarlinde L van den Boogaard, Rurika Oka, Anne Hakkert, et al.
The EMBO Journal|June 14, 2012
The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markersJavier Muñoz, Daniel E Stange, Arnout G Schepers, et al.
Acta Neuropathologica|November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.
Cancer Research|December 2, 2021
Mesenchymal-Type Neuroblastoma Cells Escape ALK InhibitorsEllen M Westerhout, Mohamed Hamdi, Peter Stroeken, et al.
JCO Precision Oncology|May 26, 2021
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease PanelEsther M van Wezel, Lieke M J van Zogchel, Jalenka van Wijk, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 26, 2017
Indian Hedgehog Suppresses a Stromal Cell-Driven Intestinal Immune ResponseB Florien Westendorp, Nikè V J A Büller, Olga N Karpus, et al.
Pageof 14